Skip to content

Stanford Cardiac Invasive Electrophysiology Novel Computer Experience

Stanford Cardiac Invasive Electrophysiology Novel Computer Experience (SCIENCE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03549806
Acronym
SCIENCE
Enrollment
11
Registered
2018-06-08
Start date
2018-06-21
Completion date
2021-01-11
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, Atrial Tachycardia

Keywords

Atrium, tachyarrhythmias

Brief summary

This study will test the ability of computer algorithms to predict successful ablation therapy for atrial arrhythmias.

Detailed description

Patients will be recruited prospectively from among those undergoing ablation for atrial fibrillation (AF) or atrial tachycardias (AT) which may be reentrant or focal. Each patient will undergo careful data collection, including electrogram data and sites of ablation lesions. Ablation will proceed in operator-dependent fashion, and will not be modified in any way for this study. The research question is whether algorithms based on data such as electrograms and details of the ablation performed can predict which patients will have a successful case. Primary endpoints are measures of clinical success defined by (a) acute termination of atrial arrhythmia during the case; (b) long-term reduction in arrhythmia burden; (c) long-term freedom from arrhythmia. Secondary endpoints include (a) identification of sites of arrhythmia termination; (b) improved clinical status.

Interventions

DIAGNOSTIC_TESTNo Intervention. Test is computer algorithm.

Diagnostic algorithms (test) will be run on already acquired clinical data. No study intervention in operator-prescribed clinical ablation. Predictive accuracy of test for study outcome will then be determined in follow-up

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing catheter ablation for atrial arrhythmias

Exclusion criteria

* Inability to sign informed consent * Expected survival \< 1 year * Extreme comorbidity, such as advanced NYHA Class III/IV heart failure, dialysis, series stroke.

Design outcomes

Primary

MeasureTime frameDescription
Reduction in AF burden on follow-up2 yearsReduction in amount of arrhythmia per unit time, compared to prior to the procedure.
Freedom from arrhythmia on follow-up2 yearsAbsence of arrhythmia, defined by clinical thresholds.

Secondary

MeasureTime frameDescription
Clinical status as measured by the EQ5D2 yearsPatient feeling better subjectively in EQ5D

Other

MeasureTime frameDescription
Acute Impact of AblationDay zero (that is, during procedure).Documentation of whether ablation acutely eliminated atrial fibrillation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026